Toxoplasma gondii infection in a group of schizophrenic colombian patients

Jaime Valero; Juan F. Cano; Rodrigo Nel Cordoba Rojas; Ligia Alejandra De la Torre Cifuentes; Laura Ramirez

Toxoplasma gondii infection in a group of schizophrenic colombian patients

Research output: Knowledge networks › Poster › peer-review

162 Downloads (Pure)

Abstract

This case- control study aims to determine if there is a higher prevalence of Toxoplasma gondii IgG antibodies in Colombian patients with schizophrenia compared with ( versus ) a group of people without this diagnosis o (healthy controls). Studies in several countries have shown a strong association between toxoplasma antibodies and schizophrenia, which has raise several hypotheses and some new visions regarding the presence of the parasite in the pathophysiology of this illness. Our secondary objective is to analyze whether there is a relationship among the existing toxoplasma strains in our country and the presence of the disease. A descriptive observational will be completed in relation to genetic and social risk factors.

Translated title of the contribution	Infección por Toxoplasma gondii en un grupo de pacientes colombianos con esquizofrenia
Original language	English (US)
Pages	613-614
Number of pages	2
State	Published - May 21 2019
Event	American Psychiatric Association (APA) 172nd Annual Meeting - Moscone Center, San Francisco, United States Duration: May 18 2019 → May 22 2019 Conference number: P8-177

Conference

Conference	American Psychiatric Association (APA) 172nd Annual Meeting
Abbreviated title	APA
Country/Territory	United States
City	San Francisco
Period	5/18/19 → 5/22/19

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

Poster-Proceedings APA 2019Final published version, 5.57 MBLicense: Unspecified

Cite this

@conference{0ceb4a5d97a3472499459f77a4f4947b,

title = "Toxoplasma gondii infection in a group of schizophrenic colombian patients",

abstract = "This case- control study aims to determine if there is a higher prevalence of Toxoplasma gondii IgG antibodies in Colombian patients with schizophrenia compared with ( versus ) a group of people without this diagnosis o (healthy controls). Studies in several countries have shown a strong association between toxoplasma antibodies and schizophrenia, which has raise several hypotheses and some new visions regarding the presence of the parasite in the pathophysiology of this illness. Our secondary objective is to analyze whether there is a relationship among the existing toxoplasma strains in our country and the presence of the disease. A descriptive observational will be completed in relation to genetic and social risk factors. ",

author = "Jaime Valero and Cano, \{Juan F.\} and \{Cordoba Rojas\}, \{Rodrigo Nel\} and \{De la Torre Cifuentes\}, \{Ligia Alejandra\} and Laura Ramirez",

note = "Yolken RH, Dickerson FB, \& Fuller-Torrey E. Toxoplasma and schizophrenia. Parasite Inmunology 2009; 31(1): 706-715; American Psychiatric Association (APA) 172nd Annual Meeting ; Conference date: 18-05-2019 Through 22-05-2019",

year = "2019",

month = may,

day = "21",

language = "English (US)",

pages = "613--614",

}

TY - CONF

T1 - Toxoplasma gondii infection in a group of schizophrenic colombian patients

AU - Valero, Jaime

AU - Cano, Juan F.

AU - Cordoba Rojas, Rodrigo Nel

AU - De la Torre Cifuentes, Ligia Alejandra

AU - Ramirez, Laura

N1 - Conference code: P8-177

PY - 2019/5/21

Y1 - 2019/5/21

N2 - This case- control study aims to determine if there is a higher prevalence of Toxoplasma gondii IgG antibodies in Colombian patients with schizophrenia compared with ( versus ) a group of people without this diagnosis o (healthy controls). Studies in several countries have shown a strong association between toxoplasma antibodies and schizophrenia, which has raise several hypotheses and some new visions regarding the presence of the parasite in the pathophysiology of this illness. Our secondary objective is to analyze whether there is a relationship among the existing toxoplasma strains in our country and the presence of the disease. A descriptive observational will be completed in relation to genetic and social risk factors.

AB - This case- control study aims to determine if there is a higher prevalence of Toxoplasma gondii IgG antibodies in Colombian patients with schizophrenia compared with ( versus ) a group of people without this diagnosis o (healthy controls). Studies in several countries have shown a strong association between toxoplasma antibodies and schizophrenia, which has raise several hypotheses and some new visions regarding the presence of the parasite in the pathophysiology of this illness. Our secondary objective is to analyze whether there is a relationship among the existing toxoplasma strains in our country and the presence of the disease. A descriptive observational will be completed in relation to genetic and social risk factors.

M3 - Poster

SP - 613

EP - 614

T2 - American Psychiatric Association (APA) 172nd Annual Meeting

Y2 - 18 May 2019 through 22 May 2019

ER -

Toxoplasma gondii infection in a group of schizophrenic colombian patients

Abstract

Conference

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Fingerprint

Cite this